Obagi’s Expansion Into Injectables Is One of the Biggest Moves in Aesthetics Right Now
For decades, Obagi has been one of the most recognizable names in medical-grade skincare. Now, the company is making a major expansion into injectables, and the industry is paying attention.
In this episode of The Dr. Randi Show, Dr. Randi sits down with Drew Fine of Obagi Medical for a conversation about the brand’s entry into HA fillers, the changing face of aesthetics, and why patients are demanding a dramatically different approach to aging than they were even a few years ago.
This conversation goes beyond products. It’s about where the industry is headed next.
Inside the episode:
• Why the era of overfilled faces is losing momentum
• Why skin quality has become the new luxury in aesthetics
• The real reason brands are racing toward longevity and regenerative beauty
• Why “undetectable” injectables are becoming the goal
• The skincare categories suddenly exploding in growth, including scalp health, lashes, brows, and NAD+ innovation
• Why the future of aesthetics may belong to brands that can connect skincare, injectables, wellness, and aging together
Drew also shares why Obagi believes this expansion marks the beginning of a much larger evolution for the brand and the industry overall.
Sponsored by NewBeauty 💄
📱 Listen and Watch on Spotify: https://spti.fi/4fQUyMM
🎧 Listen Now on Apple: https://dub.sh/48rFTfo
